Pharmacy News

Hospira Recalls One Lot of Lidocaine Injection

Kate Traynor

BETHESDA, MD 07 Oct 2013—In a customer communication (PDF)External Link dated October 4, Hospira announced the nationwide recall of a single lot of lidocaine hydrochloride injection that may contain metal particulates.

According to Hospira, the company has confirmed the presence of reddish-black oxidized stainless steel particles inside a 20-mL flip-top vial of 1% lidocaine hydrochloride injection, lot 25-090-DK. The lot number on vials in this lot may be followed by the numerals 01 or 02, the company stated.

The vials were distributed March through June of this year.

Hospira is working to identify the root cause of the problem, the company stated.

Anyone with the recalled lot in stock should quarantine the vials and contact Stericycle at 866-364-8812 from 8:00 am to 5:00 pm Eastern Time, Monday through Friday, for return and replacement of the product.


Contact Us
For questions, comments, or more information on this article, please contact the ASHP News Center at
ASHP Product Listing